Country | H. pylori prevalencea | Min. ageb | Max. agec | No.d | Methodf | Population sourceg | Level of urbanizationh | Yeari | Regionk | Reference |
---|---|---|---|---|---|---|---|---|---|---|
Algeria | 45 | 0 | 9 | 42 | Serology | Clinic | Urban | 1987 | Africa | Megraud et al. [23] |
Brazil | 36.7 | 3 | 5 | 60 | Serology | Clinic | Urban | 1992 | Americas | Oliveira et al. [24] |
Colombia | 61 | 2 | 5 | 373 | UBT | Community | Rural | 1992 | Americas | Goodman et al. [25] |
Costa Rica | 60 | 7 | 10 | 60 | Serology | Community | Rural | 1984-1988 | Americas | Sierra et al. [26] |
USA | 35 | 1 | 5 | 182 | Serology | Clinic | Both | 1998 | Americas | Elitsur et al. [27] |
China | 53 | 3 | 4 | 19 | UBT | Community | Rural | 1994 | Western Pacific | Ma et al. [28] |
India | 6 | 3 | 10 | 30 | Serology | Clinic | Urban | 1989 | Southeast Asia | Graham et al. [29] |
Japan | 12.5 | 1 | 4 | 56 | Serology | Clinic | Urban | 1994 | Western Pacific | Matsukura et al. [30] |
Korea | 6 | 1 | 3 | 52 | Serology | Clinic | Both | 1998j | Western Pacific | Malaty et al. [31] |
Vietnam | 13 | 0 | 9 | 61 | Serology | Clinic | Urban | 1987 | Western Pacific | Megraud et al. [23] |
Belgium | 6.4 | 1 | 5 | n/ae | Serology | Clinic | Both | 1995 j | Europe | Blecker et al. [32] |
Estonia | 4.9 | 9 | 9 | 94 | Serology | Community | Both | 1993-1996 | Europe | Vorobja et al. [33] |
Finland | 6 | 3 | 3 | 131 | Serology | Community | Both | 1980 | Europe | Ashorn et al. [34] |
France | 4 | 0 | 9 | 113 | Serology | Clinic | Urban | 1987 | Europe | Megraud et al. [23] |
Germany | 8.3 | 3 | 5 | 36 | Serology | Clinic | Urban | 1984 | Europe | Hornemann et al. [35] |
Iceland | 9 | 0 | 9 | 13 | Serology | Clinic | Both | 1991-1992 | Europe | Bergenzaum et al. [36] |
Italy | 22 | 1 | 10 | 32 | Serology | Clinic | Urban | 1995 | Europe | Luzza et al. [37] |
Netherlands | 9 | 6 | 8 | 80 | Serology | Clinic | Urban | 1993 | Europe | Roosendaal et al. [38] |
Poland | 16.6 | 3 | 5 | 60 | Serology | Clinic | Urban | 1996 | Europe | Czkwianianc et al. [39] |
Portugal | 42.6 | 3 | 6 | n/ae | Serology | Clinic | Urban | 1994 j | Europe | Quina et al. [40] |
Russia | 30 | 1 | 4 | 44 | Serology | Community | Urban | 1996 | Europe | Malaty et.al [41] |
Spain | 11 | 2 | 9 | 203 | Serology | Clinic | Both | 1991-1992 | Europe | Cilla et al. [42] |
Sweden | 7.7 | 1 | 4 | 661 | Serology | Clinic | Urban | 1984-1995 | Europe | Grandstorm et al. [43] |
Switzerland | 7 | 5 | 7 | 432 | UBT | Community | Both | 1998 | Europe | Boltshauser et al. [44] |
Australia | 25 | 2 | 4 | 20 | Serology | Clinic | Urban | 1991 | Western Pacific | Hardikar et al. [45] |
Gambia | 31 | 0 | 5 | 353 | Serology | Community | Rural | 1990 | Africa | Sullivan et al. [46] |
Singapore | 3 | 0 | 4 | 305 | Serology | Community | Urban | 1992 | Western Pacific | [17] |
Thailand | 74 | 1 | 4 | 27 | Serology | Community | Urban | 1990 | Southeast Asia | Perez-Perez et al. [18] |